Read more

January 15, 2020
1 min read
Save

FDA OKs rapid-acting insulin for kids with diabetes — other top stories in endocrinology

The FDA’s approval of a rapid-acting insulin for children with diabetes was one of the top stories in endocrinology last week.

Another top story was about a report that linked excess weight in toddlerhood with a quadrupled risk for overweight or obesity in adolescence.

Check out all the top stories in endocrinology below.

FDA approves rapid-acting insulin for children with diabetes

On Jan. 6, the FDA approved fast-acting insulin aspart 100 U/mL as a mealtime insulin for children with diabetes, according to a press release from Novo Nordisk. Read more.

Child with insulin 2019 adobe.  
The FDA’s approval of a rapid-acting insulin for children with diabetes was one of the top stories in endocrinology last week.

Source:Adobe

Excess weight at 3 years quadruples obesity risk in adolescence

Excess weight at age 3 years is associated with higher risk for overweight or obesity at age 15 years, according to findings published in Pediatric Obesity. Read more.

Bariatric surgery leads to greater weight loss, diabetes remission irrespective of procedure type

Chinese adults with obesity and type 2 diabetes lose more weight and are more likely to achieve diabetes and dyslipidemia remission at 5 years when treated with bariatric surgery than with nonsurgical options, with similar effectiveness for bypass and restrictive procedures, according to findings published in Diabetes/Metabolism Research and Reviews. Read more.

Risk for autoimmune skin condition may be elevated by DPP-IV use

The skin condition bullous pemphigoid may be more likely to develop in adults with type 2 diabetes who use DPP-IV inhibitors vs. those who do not use the medication, especially if they also use spironolactone or have dementia, according to findings published in the Journal of Diabetes and its Complications. Read more.

Maternal caffeine intake during pregnancy associated with pediatric abdominal, liver fat

Children born to mothers who consumed at least 360 mg caffeine per day during pregnancy are more likely to have a higher BMI and greater total body, abdominal and liver fat masses compared with children born to mothers who consumed 90 mg or less caffeine per day, according to findings from a population-based study. Read more.